Catania, September 20, 2019 - SIFI, Italian leader in the development and marketing of innovative ophthalmic therapies, is pleased to announce a new important appointment in the company's organization. Fabrizio Folco has joined the company as Country Manager Italy, and will be responsible for accelerating company development on the Italian market, through management of the company's commercial strategy and organization, for both pharma and surgical areas.

Fabrizio was previously at Vifor Pharma, a global pharmaceutical company operating in iron deficiency, nephrology and cardio-renal therapeutic solutions. During his professional career he has held roles of increasing importance, developing skills in the areas of General Management, Business Insight, Sales and Marketing, both nationally and internationally.

"We are delighted that Fabrizio has decided to join SIFI" stated Fabrizio Chines, President and CEO of SIFI "The Italian market has always played a key role for the group. We are convinced that Fabrizio, with the experience gained in different therapeutic areas, can bring knowledge and innovative operating models in ophthalmology, to accelerate growth and fulfill SIFI's potential in the internal market."

Fabrizio Folco will report directly to Gilberto Dalesio, SIFI Chief Commercial Officer.

SIFI is the leading Italian ophthalmic company, focused on eye care since 1935 with the mission to improve people’s lives through meaningful innovation in eye care. SIFI designs, manufactures and markets innovative pharmaceutical specialty products, nutraceuticals, surgical and medical devices. 

Headquartered in Catania, Sicily, SIFI operates directly in Italy, France, Spain, Romania, Turkey and Mexico with a staff of more than 400 people worldwide. Since June 2015, SIFI is backed by the private equity 21 Invest to support the company’s international expansion and portfolio development strategy. More information available at www.sifigroup.com.